Kobayashi Pharmaceutical Co., Ltd. (4967.T)
JPY 5942.0
(-0.05%)
JPY 5942.0
(-0.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 173.45 Billion | 166.25 Billion | 155.25 Billion | 150.51 Billion | 168.05 Billion | 167.47 Billion |
| Cost of Revenue | 80.28 Billion | 73.92 Billion | 66.47 Billion | 65.24 Billion | 64.7 Billion | 64.35 Billion |
| Gross Profit | 93.17 Billion | 92.33 Billion | 88.77 Billion | 85.26 Billion | 103.34 Billion | 103.12 Billion |
| Operating Expenses | 70.59 Billion | 65.65 Billion | 62.7 Billion | 59.31 Billion | 76.98 Billion | 76.82 Billion |
| Selling, General and Administrative Expenses | 57.61 Billion | 31.6 Billion | 31.79 Billion | 31.15 Billion | 47.76 Billion | 47.73 Billion |
| Research and Development Expenses | 9 Billion | 8.32 Billion | 7.52 Billion | 7.33 Billion | 7.11 Billion | 7.03 Billion |
| Other Expenses | 3.98 Billion | 25.72 Billion | 23.39 Billion | 20.82 Billion | 22.11 Billion | 22.06 Billion |
| Cost and Expenses | 147.67 Billion | 139.58 Billion | 129.18 Billion | 124.56 Billion | 141.69 Billion | 141.18 Billion |
| Operating Income | 25.78 Billion | 26.66 Billion | 26.06 Billion | 25.94 Billion | 26.35 Billion | 26.28 Billion |
| Interest Expense | 29 Million | 18 Million | 18 Million | 21 Million | 20 Million | 35 Million |
| Income Tax Expense | 7.22 Billion | 7.92 Billion | 7.92 Billion | 7.43 Billion | 7.66 Billion | 7.28 Billion |
| Earnings before Tax | 27.55 Billion | 27.95 Billion | 27.63 Billion | 26.63 Billion | 26.8 Billion | 25.3 Billion |
| Net Income | 20.33 Billion | 20.02 Billion | 19.71 Billion | 19.2 Billion | 19.13 Billion | 18.02 Billion |
| Earnings Per Share Basic | 268.16 | 259.61 | 252.35 | 245.70 | 244.07 | 228.04 |
| Earnings Per Share Diluted | 268.16 | 259.58 | 252.35 | 245.70 | 244.07 | 227.95 |
| Weighted Average Shares Outstanding | 75.84 Million | 77.12 Million | 78.12 Million | 78.16 Million | 78.41 Million | 79.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.84 Million | 77.13 Million | 78.12 Million | 78.16 Million | 78.41 Million | 79.06 Million |
| Gross Margin | 0.54 | 0.56 | 0.57 | 0.57 | 0.61 | 0.62 |
| EBIT Margin | 0.18 | 0.20 | 0.21 | 0.21 | 0.19 | 0.18 |
| Profit Margin | 0.12 | 0.12 | 0.13 | 0.13 | 0.11 | 0.11 |
| EBITDA | 31.68 Billion | 31.86 Billion | 30.78 Billion | 29.91 Billion | 30.33 Billion | 29.59 Billion |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.17 | 0.17 | 0.16 | 0.16 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 36.65 Billion | 36.48 Billion | 54.34 Billion | 173.45 Billion | 45.49 Billion | 40.15 Billion |
| Cost of Revenue | 17.2 Billion | 15.87 Billion | 27.83 Billion | 80.28 Billion | 19.87 Billion | 16.99 Billion |
| Gross Profit | 19.44 Billion | 20.6 Billion | 26.5 Billion | 93.17 Billion | 25.61 Billion | 23.16 Billion |
| Operating Expenses | 15 Billion | 15.57 Billion | 19.18 Billion | 67.39 Billion | 16.63 Billion | 17.81 Billion |
| Selling, General and Administrative Expenses | 12.78 Billion | 13.64 Billion | 16.41 Billion | - | 14.19 Billion | 15.3 Billion |
| Research and Development Expenses | 2.21 Billion | 1.93 Billion | 2.77 Billion | - | 2.16 Billion | 2.25 Billion |
| Other Expenses | 93 Million | 192 Million | -25 Million | -930 Million | 622 Million | 176 Million |
| Cost and Expenses | 32.2 Billion | 31.45 Billion | 47.01 Billion | 147.67 Billion | 36.5 Billion | 34.81 Billion |
| Operating Income | 4.44 Billion | 5.02 Billion | 7.32 Billion | 25.78 Billion | 8.98 Billion | 5.34 Billion |
| Interest Expense | 13 Million | 4 Million | 6 Million | 29 Million | 12 Million | 7 Million |
| Income Tax Expense | 208 Million | 610 Million | 1.58 Billion | 7.22 Billion | 2.44 Billion | 1.7 Billion |
| Earnings before Tax | 669 Million | 1.58 Billion | 6.42 Billion | 27.55 Billion | 10.07 Billion | 5.96 Billion |
| Net Income | 460 Million | 976 Million | 4.84 Billion | 20.33 Billion | 7.63 Billion | 4.25 Billion |
| Earnings Per Share Basic | 6.19 | 13.13 | 64.48 | - | 100.28 | 55.91 |
| Earnings Per Share Diluted | 6.19 | 13.13 | 64.48 | - | 100.28 | 55.91 |
| Weighted Average Shares Outstanding | 74.33 Million | 74.33 Million | 75.03 Million | 75.84 Million | 76.12 Million | 76.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.33 Million | 74.33 Million | 75.03 Million | 75.84 Million | 76.12 Million | 76.12 Million |
| Gross Margin | 0.53 | 0.56 | 0.49 | 0.54 | 0.56 | 0.58 |
| EBIT Margin | 0.18 | 0.19 | 0.17 | - | 0.21 | 0.15 |
| Profit Margin | 0.01 | 0.03 | 0.09 | 0.12 | 0.17 | 0.11 |
| EBITDA | 6.51 Billion | 6.81 Billion | 9.08 Billion | - | 9.72 Billion | 6.04 Billion |
| Earnings Before Tax Margin | 0.12 | 0.14 | 0.13 | 0.15 | 0.20 | 0.13 |
005430
1909
FGEN
CASP
9304
002478